Neurocrine Biosciences (NBIX) Depreciation & Amortization (CF) (2009 - 2026)
Neurocrine Biosciences (NBIX) posted Depreciation & Amortization (CF) of $9 million for Q3 2026, up 34.3% from $6.7 million a year earlier and up 7.1% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Depreciation & Amortization (CF) at Neurocrine Biosciences was $31 million, up 20.2% year-over-year; for FY2025, it was $26 million, up 10.6% from FY2024.
- Annual Depreciation & Amortization (CF) has increased for 13 consecutive years, with a five-year compound annual growth rate of 24.8% (FY2020 to FY2025).
- In prior years, Neurocrine Biosciences' Depreciation & Amortization (CF) was $23.5 million in FY2024 (+32.0%), $17.8 million in FY2023 (+17.9%), $15.1 million in FY2022 (+38.5%) and $10.9 million in FY2021 (+26.7%).
- The Q3 2026 figure stands as the highest quarterly Depreciation & Amortization (CF) in data going back to Q3 2010.
- On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last five quarters, with growth averaging 18.6% over the last eight quarters.
- The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q2 2024, with growth of 52.4%; the weakest was Q2 2025, with a decline of 1.6%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $8.4 million (Q2 2026), $7.2 million (Q1 2026) and $6.4 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 9.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 9.00 Mn |
| Jun 30, 2026 | 8.40 Mn |
| Mar 31, 2026 | 7.20 Mn |
| Dec 31, 2025 | 6.40 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Jun 30, 2025 | 6.30 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Sep 30, 2024 | 5.60 Mn |
| Jun 30, 2024 | 6.40 Mn |
| Mar 31, 2024 | 5.30 Mn |
| Dec 31, 2023 | 4.90 Mn |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | 4.20 Mn |
| Mar 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 3.90 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 3.90 Mn |
| Mar 31, 2022 | 3.30 Mn |
| Dec 31, 2021 | 3.00 Mn |
API Access
Neurocrine Biosciences Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();